These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 22920235

  • 41. Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis.
    Kerekes G, Soltész P, Szucs G, Szamosi S, Dér H, Szabó Z, Csáthy L, Váncsa A, Szodoray P, Szegedi G, Szekanecz Z.
    Isr Med Assoc J; 2011 Mar; 13(3):147-52. PubMed ID: 21608334
    [Abstract] [Full Text] [Related]

  • 42. Circulating progenitor cells in rheumatoid arthritis: association with inflammation and oxidative stress.
    Lo Gullo A, Mandraffino G, Sardo MA, D'Ascola A, Mamone F, Loddo S, Alibrandi A, Imbalzano E, Mandraffino R, Mormina E, Saitta C, Lo Gullo R, David A, Saitta A.
    Scand J Rheumatol; 2014 Mar; 43(3):184-93. PubMed ID: 24313545
    [Abstract] [Full Text] [Related]

  • 43. Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis.
    Chen YS, Yan W, Geczy CL, Brown MA, Thomas R.
    Arthritis Res Ther; 2009 Mar; 11(2):R39. PubMed ID: 19284577
    [Abstract] [Full Text] [Related]

  • 44. Low Endogenous Secretory Receptor for Advanced Glycation End-Products Levels Are Associated With Inflammation and Carotid Atherosclerosis in Prediabetes.
    Di Pino A, Urbano F, Zagami RM, Filippello A, Di Mauro S, Piro S, Purrello F, Rabuazzo AM.
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1701-9. PubMed ID: 26885882
    [Abstract] [Full Text] [Related]

  • 45. Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients.
    Georgiadis AN, Voulgari PV, Argyropoulou MI, Alamanos Y, Elisaf M, Tselepis AD, Drosos AA.
    Semin Arthritis Rheum; 2008 Aug; 38(1):13-9. PubMed ID: 18191989
    [Abstract] [Full Text] [Related]

  • 46. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
    Jang Y, Kim JY, Kang SM, Kim JS, Chae JS, Kim OY, Koh SJ, Lee HC, Ahn CW, Song YD, Lee JH.
    Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
    [Abstract] [Full Text] [Related]

  • 47. Independent relationship of osteoprotegerin concentrations with endothelial activation and carotid atherosclerosis in patients with severe rheumatoid arthritis.
    Dessein PH, López-Mejias R, González-Juanatey C, Genre F, Miranda-Filloy JA, Llorca J, González-Gay MA.
    J Rheumatol; 2014 Mar; 41(3):429-36. PubMed ID: 24488413
    [Abstract] [Full Text] [Related]

  • 48. Clinical improvement in rheumatoid arthritis is associated with healthier microvascular function in patients who respond to antirheumatic therapy.
    Galarraga B, Belch JJ, Pullar T, Ogston S, Khan F.
    J Rheumatol; 2010 Mar; 37(3):521-8. PubMed ID: 20080919
    [Abstract] [Full Text] [Related]

  • 49. Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE.
    Moriya S, Yamazaki M, Murakami H, Maruyama K, Uchiyama S.
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(10):2540-2546. PubMed ID: 25282185
    [Abstract] [Full Text] [Related]

  • 50. Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study.
    Vermeer M, Kuper HH, Hoekstra M, Haagsma CJ, Posthumus MD, Brus HL, van Riel PL, van de Laar MA.
    Arthritis Rheum; 2011 Oct; 63(10):2865-72. PubMed ID: 21647867
    [Abstract] [Full Text] [Related]

  • 51. Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease.
    Mathieu S, Joly H, Baron G, Tournadre A, Dubost JJ, Ristori JM, Lusson JR, Soubrier M.
    Rheumatology (Oxford); 2008 Aug; 47(8):1203-7. PubMed ID: 18524805
    [Abstract] [Full Text] [Related]

  • 52. Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints.
    Aletaha D, Smolen JS.
    Arthritis Rheum; 2011 Dec; 63(12):3702-11. PubMed ID: 21953215
    [Abstract] [Full Text] [Related]

  • 53. Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study.
    Angel K, Provan SA, Fagerhol MK, Mowinckel P, Kvien TK, Atar D.
    Am J Hypertens; 2012 Jun; 25(6):644-50. PubMed ID: 22378036
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Cardiovascular risk assessment in patients with rheumatoid arthritis: a correlative study of noninvasive arterial health testing.
    Scanlon EM, Mankad R, Crowson CS, Kullo IJ, Mulvagh SL, Matteson EL, Kvrgic Z, Davis JM.
    Clin Rheumatol; 2017 Apr; 36(4):763-771. PubMed ID: 27988813
    [Abstract] [Full Text] [Related]

  • 57. Detection of feto-maternal infection/inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot study.
    Hájek Z, Germanová A, Koucký M, Zima T, Kopecký P, Vítkova M, Parízek A, Kalousová M.
    J Perinat Med; 2008 Apr; 36(5):399-404. PubMed ID: 18771410
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Soluble receptor for advanced glycation end-products independently influences individual age-dependent increase of arterial stiffness.
    Gelžinský J, Mayer O, Seidlerová J, Mateřánková M, Mareš Š, Kordíková V, Trefil L, Cífková R, Filipovský J.
    Hypertens Res; 2020 Feb; 43(2):111-120. PubMed ID: 31636359
    [Abstract] [Full Text] [Related]

  • 60. Advanced glycation end-products inhibition improves endothelial dysfunction in rheumatoid arthritis.
    Syngle A, Vohra K, Garg N, Kaur L, Chand P.
    Int J Rheum Dis; 2012 Feb; 15(1):45-55. PubMed ID: 22324946
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.